H Josef Vormoor (Josef Vormoor)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 8

Top Topics

Community Dwelling

Acute Lymphoblastic Leukemia

Mass Spectrometry

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Emma Jacobine Verwaaijen, Patrick van der Torre, H Josef Vormoor, Rob Pieters, Marta Fiocco, Annelies Hartman, Marry M van den Heuvel-Eibrink
Novel Adaption of the SARC-F Score to Classify Pediatric Hemato-Oncology Patients with Functional Sarcopenia. Cancers 15 (1) (2023)
Emma Jacobine Verwaaijen, Patrick van der Torre, H Josef Vormoor, Rob Pieters, Marta Fiocco, Annelies Hartman, Marry M van den Heuvel-Eibrink
Novel Adaption of the SARC-F Score to Classify Pediatric Hemato-Oncology Patients with Functional Sarcopenia. Cancers 15 (1) (2023)
Emma Jacobine Verwaaijen, Patrick van der Torre, H Josef Vormoor, Rob Pieters, Marta Fiocco, Annelies Hartman, Marry M van den Heuvel-Eibrink
Novel Adaption of the SARC-F Score to Classify Pediatric Hemato-Oncology Patients with Functional Sarcopenia. Cancers 15 (1) (2023)
Ivana Bozovic Spasojevic, Andrea C Ferrari, Johan De Munter, Ashley Gamble, Assia Konsoulova, Katie Rizvi, Carina Schneider, Marie Balsat, Anna Castleton, Leila Gofti-Laroche, Anita Kienesberger, Beate Timmermann, H Josef Vormoor, Emmanouil Saloustros, Daniel P Stark
Have we made progress in taking care of adolescents and young adults with cancer? Results of a European multi-professional survey. Tumori (2023)
Emma Jacobine Verwaaijen, Patrick van der Torre, H Josef Vormoor, Rob Pieters, Marta Fiocco, Annelies Hartman, Marry M van den Heuvel-Eibrink
Novel Adaption of the SARC-F Score to Classify Pediatric Hemato-Oncology Patients with Functional Sarcopenia. Cancers 15 (1) (2023)
Claudia Rossig, Andrew D J Pearson, Gilles Vassal, Nicole Scobie, Nicholas Bird, Patricia Blanc, H Josef Vormoor, Friso G Calkoen, Franco Locatelli, Francesca Del Bufalo, Susana Rives, Elad Jacoby, Adriana Cristina Balduzzi, Jean-Pierre Bourquin, Andre Baruchel, null null
Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Linde Dekker, Friso G Calkoen, Yilin Jiang, Hilly Blok, Saskia R Veldkamp, Coco De Koning, Maike Spoon, Rick Admiraal, Peter Hoogerbrugge, Britta Vormoor, H Josef Vormoor, Henk Visscher, Marc Bierings, Marieke Van Der Vlugt, Harm Van Tinteren, A Laura Nijstad, Alwin D R Huitema, Kim C M Van Der Elst, Rob Pieters, Caroline A Lindemans, Stefan Nierkens
Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemia. Blood advances 6 (7) (2022)
Jordy C G van der Zwet, Jessica G C A M Buijs-Gladdines, Valentina Cordoʹ, Donna O Debets, Willem K Smits, Zhongli Chen, Jelle Dylus, Guido J R Zaman, Maarten Altelaar, Koichi Oshima, Beat C Bornhauser, Jean-Pierre Bourquin, Jan Cools, Adolfo A Ferrando, H Josef Vormoor, Rob Pieters, Britta Vormoor, Jules P P Meijerink
MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance. Leukemia 35 (12) (2021)